Obstructive nephropathy: Towards biomarker discovery and gene therapy

Nature Clinical Practice Nephrology

Volumn 2, Issue 3, 2006, Pages 157-168

  Chevalier, Robert L ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Apoptosis; Fibrosis; Obstructive nephropathy; Obstructive uropathy; Ureteral obstruction

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; BIOLOGICAL MARKER; CD11B ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR CCR2; COLONY STIMULATING FACTOR 1; CONNECTIVE TISSUE GROWTH FACTOR; CYTOKINE; DEATH ASSOCIATED PROTEIN KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; OSTEOPONTIN; PLATELET DERIVED GROWTH FACTOR; PROTEIN BCL 2; RHO KINASE; SMAD3 PROTEIN; SMAD7 PROTEIN; SOMATOMEDIN BINDING PROTEIN; STRESS ACTIVATED PROTEIN KINASE 1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

CELL CULTURE; CELL INTERACTION; CELL PROLIFERATION; DISEASE COURSE; FIBROSING ALVEOLITIS; GENE DELETION; GENE EXPRESSION; GENE THERAPY; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY STRUCTURE; MACROPHAGE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION; TUBULAR DYSFUNCTION; UPREGULATION; URETER OBSTRUCTION; URINARY TRACT OBSTRUCTION;

APOPTOSIS; BIOLOGICAL MARKERS; EPIDERMAL GROWTH FACTOR; FIBROSIS; GENE THERAPY; HUMANS; INFLAMMATION; KIDNEY; MONOCYTE CHEMOATTRACTANT PROTEINS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; URETERAL OBSTRUCTION;

EID: 33644820025     PISSN: 17458323     EISSN: 17458331     Source Type: Journal    
DOI: 10.1038/ncpneph0098     Document Type: Review

References (124)

1. Seikaly MG et al. (2003) Chronic renal insufficiency in children: the 2001 annual report of the NAPRTCS. Pediatr Nephrol 18: 796-804
2. Chevalier RL and Peters CA (2003) Congenital urinary tract obstruction: proceedings of the state-of-the-art strategic planning workshop - National Institutes of Health, Bethesda, Maryland, USA, 11-12 March 2002. Pediatr Nephrol 18: 576-606
3. Iwano M et al. (2002) Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110: 341-350
4. Chevalier RL and Cachat F (2001) Role of angiotensin II in chronic ureteral obstruction. In The Renin-Angiotensin System and Progression of Renal Diseases, 250-260 (Ed. Wolf G) Basel: Karger
5. Ichikawa I et al. (2002) Paradigm shift from classic anatomic theories to contemporary cell biological views of CAKUT. Kidney Int 61: 889-898
6. Morrissey JJ and Klahr S (1997) Enalapril decreases nuclear factor κB activation in the kidney with ureteral obstruction. Kidney Int 52: 926-933
7. Klahr S and Morrissey J (2002) Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol 283: F861-F875
8. Miyajima A et al. (2003) Novel nuclear factor κB activation inhibitor prevents inflammatory injury in unilateral ureteral obstruction. J Urol 169: 1559-1563
9. Nakatani T et al. (2002) Role of renin-angiotensin system and nuclear factor-κB in the obstructed kidney of rats with unilateral ureteral obstruction. Jpn J Pharmacol 90: 361-364
10. Satoh M et al. (2001) Renal interstitial fibrosis is reduced in angiotensin II type 1a receptor-deficient mice. J Am Soc Nephrol 12: 317-325
11. Tashiro K et al. (2003) Attenuation of renal fibrosis by proteasome inhibition in rat obstructive nephropathy: possible role of nuclear factor κB. Int J Mol Med 12: 587-592
12. Nagatoya K et al. (2002) Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction. Kidney Int 61: 1684-1695
13. Lange-Sperandio B et al. (2002) Selectins mediate macrophage infiltration in obstructive nephropathy in newborn mice. Kidney Int 61: 516-524
14. Naruse T et al. (2002) P-selectin-dependent macrophage migration into the tubulointerstitium in unilateral ureteral obstruction. Kidney Int 62: 94-105
15. Ogawa D et al. (2004) Cerebroside sulfotransferase deficiency ameliorates L-selectin-dependent monocyte infiltration in the kidney after ureteral obstruction. J Biol Chem 279: 2085-2090
16. Takeda A et al. (2000) Role of leukocyte adhesion molecules in monocyte/macrophage infiltration in weanling rats with unilateral ureteral obstruction. Int J Urol 7: 415-420
17. Lange-Sperandio B et al.: Distinct roles of Mac-1 and its counter-receptors in neonatal obstructive nephropathy. Kidney Int, in press
18. Cheng QL et al. (2000) Effects of ICAM-1 antisense oligonucleotide on the tubulointerstitium in mice with unilateral ureteral obstruction. Kidney Int 57: 183-190
19. Yamagishi H et al. (2001) Genetically modified bone marrow-derived vehicle cells site specifically deliver an anti-inflammatory cytokine to inflamed interstitium of obstructive nephropathy. J Immunol 166: 609-616
20. Vielhauer V et al. (2001) Obstructive nephropathy in the mouse: progressive fibrosis correlates with tubulointerstitial chemokine expression and accumulation of CC chemokine receptor 2- and 5-positive leukocytes. J Am Soc Nephrol 12: 1173-1187
21. Wada T et al. (2004) Gene therapy via blockade of monocyte chemoattractant protein-1 for renal fibrosis. J Am Soc Nephrol 15: 940-948
22. Pittock ST et al. (2005) MCP-1 is up-regulated in unstressed and stressed HO-1 knockout mice: pathophysiologic correlates. Kidney Int 68: 611-622
23. Lenda DM et al. (2003) Reduced macrophage recruitment, proliferation, and activation in colony-stimulating factor-1-deficient mice results in decreased tubular apoptosis during renal inflammation. J Immunol 170: 3254-3262
24. Kitagawa K et al. (2004) Blockade of CCR2 ameliorates progressive fibrosis in kidney. Am J Pathol 165: 237-246
25. Eis V et al. (2004) Chemokine receptor CCR1 but not CCR5 mediates leukocyte recruitment and subsequent renal fibrosis after unilateral ureteral obstruction. J Am Soc Nephrol 15: 337-347
26. Anders HJ et al. (2002) A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation. J Clin Invest 109: 251-259
27. Lange-Sperandio B et al. (2005) A2A adenosine receptor agonist and PDE4 inhibition delays inflammation but fails to reduce injury in experimental obstructive nephropathy. Nephron Exp Nephrol 100: e113-e123
28. Schaier M et al. (2003) Retinoid agonist isotretinoin ameliorates obstructive renal injury. J Urol 170: 1398-1402
29. Hochberg D et al. (2000) Interstitial fibrosis of unilateral ureteral obstruction is exacerbated in kidneys of mice lacking the gene for inducible nitric oxide synthase. Lab Invest 80: 1721-1728
30. Ito K et al. (2004) Liposome-mediated transfer of nitric oxide synthase gene improves renal function in ureteral obstruction in rats. Kidney Int 66: 1365-1375
31. Chevalier RL (2004) Promise for gene therapy in obstructive nephropathy. Kidney Int 66: 1709-1710
32. Ophascharoensuk V et al. (1999) Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int 56: 571-580
33. Rouschop KMA et al. (2004) CD44 deficiency increases tubular damage but reduces renal fibrosis in obstructive nephropathy. J Am Soc Nephrol 15: 674-686
34. Zhang G et al. (2003) Urokinase receptor modulates cellular and angiogenic responses in obstructive nephropathy. J Am Soc Nephrol 14: 1234-1253
35. Nishida M et al. (2002) Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis. J Clin Invest 110: 1859-1868
36. Gobe GC and Axelsen RA (1987) Genesis of renal tubular atrophy in experimetal hydronephrosis in the rat. Lab Invest 56: 273-281
37. Cachat F et al. (2003) Ureteral obstruction in neonatal mice elicits segment-specific tubular cell responses leading to nephron loss. Kidney Int 63: 564-575
38. Miyajima A et al. (2000) Interaction of nitric oxide and transforming growth factor-β1 induced by angiotensin II and mechanical stretch in rat renal tubular epithelial cells. J Urol 164: 1729-1734
39. Dai C et al. (2003) Transforming growth factor-β1 potentiates renal tubular epithelial cell death by a mechanism independent of Smad signaling. J Biol Chem 278: 12537-12545
40. Choi YJ et al. (2001) Role of p53-dependent activation of caspases in chronic obstructive uropathy: evidence from p53 null mutant mice. J Am Soc Nephrol 12: 983-992
41. Miyajima A et al. (2000) Antibody to transforming growth factor-β ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int 58: 2301-2313
42. Bhaskaran M et al. (2003) Angiotensin II induces apoptosis in renal proximal tubular cells. Am J Physiol 284: F955-F965
43. Inguaggiato P et al. (2001) Cellular overexpression of heme oxygenase-1 up-regulates p21 and confers resistance to apoptosis. Kidney Int 60: 2181-2191
44. Power RE et al. (2004) Mechanical deformation induced apoptosis in human proximal renal tubular epithelial cells is caspase dependent. J Urol 171: 457-461
45. Miyajima A et al. (2001) Role of nitric oxide in renal tubular apoptosis of unilateral ureteral obstruction. Kidney Int 59: 1290-1303
46. Chevalier RL et al. (1998) Obstructive nephropathy in the neonatal rat is attenuated by epidermal growth factor. Kidney Int 54: 38-47
47. Chevalier RL et al. (2000) Renal tubulointerstitial injury from ureteral obstruction in the neonatal rat is attenuated by IGF-1. Kidney Int 57: 882-890
48. Nguyen HT et al. (2000) Heparin-binding EGF-like growth factor is up-regulated in the obstructed kidney in a cell- and region-specific manner and acts to inhibit apoptosis. Am J Pathol 156: 889-898
49. Chung KH and Chevalier RL (1996) Arrested development of the neonatal kidney following chronic ureteral obstruction. J Urol 155: 1139-1144
50. Kiley SC et al. (2005) Epidermal growth factor potentiates renal cell death in hydronephrotic neonatal mice, but cell survival in rats. Kidney Int 68: 504-514
51. Kiley SC et al.: Of mice and men: species differences in epidermal growth factor signaling determine renal cell survival or death. J Am Soc Nephrol, in press
52. Lange-Sperandio B et al. (2003) Macrophages induce apoptosis in proximal tubule cells. Pediatr Nephrol 18: 335-341
53. Misseri R et al. (2004) TNF-α mediates obstruction-induced renal tubular cell apoptosis and proapoptotic signaling. Am J Physiol 288: F406-F411
54. Malik RK et al. (2001) Renal apoptosis parallels ceramide content following chronic ureteral obstruction in the neonatal rat. Am J Physiol 281: F56-F61
55. Basnakian AG et al. (2004) Ceramide synthesis is essential for endonuclease-mediated death of renal tubular epithelial cells induced by hypoxia-reoxygenation. Am J Physiol 288: F308-F314
56. Sunami R et al. (2004) Acatalasemia sensitizes renal tubular epithelial cells to apoptosis and exacerbates renal fibrosis after unilateral ureteral obstruction. Am J Physiol 286: F1030-F1038
57. Kinter M et al. (1999) Unilateral ureteral obstruction impairs renal antioxidant enzyme activation during sodium depletion. Kidney Int 55: 1327-1334
58. Moriyama T et al. (2001) Fluvastatin suppresses oxidative stress and fibrosis in the interstitium of mouse kidneys with unilateral ureteral obstruction. Kidney Int 59: 2095-2103
59. Pat B et al. (2005) Activation of ERK in renal fibrosis after unilateral ureteral obstruction: modulation by antioxidants. Kidney Int 67: 931-943
60. Kiley SC et al. (2003) Growth factor-mediated phosphorylation of proapoptotic BAD reduces tubule cell death in vitro and in vivo. Kidney Int 63: 33-42
61. Chevalier RL et al. (2000) Chronic ureteral obstruction in the rat suppresses renal tubular bcl-2 and stimulates apoptosis. Exp Nephrol 8: 115-122
62. Peherstorfer E et al. (2002) Effects of microinjection of synthetic Bcl-2 domain peptides on apoptosis of renal tubular epithelial cells. Am J Physiol 283: F190-F196
63. Gao X et al. (2002) Hepatocyte growth factor gene therapy retards the progression of chronic obstructive nephropathy. Kidney Int 62: 1238-1248
64. Yukawa K et al. (2004) Deletion of the kinase domain in death-associated protein kinase attenuates renal tubular cell apoptosis in chronic obstructive uropathy. Int J Mol Med 13: 515-520
65. Hughes J and Johnson RJ (1999) Role of Fas (CD95) in tubulointerstitial disease induced by unilateral ureteric obstruction. Am J Physiol 277: F26-F32
66. Hruska KA et al. (2000) Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction. Am J Physiol Renal Physiol 279: F130-F143
67. Kip1 safeguards against inflammatory injury. Nat Med 4: 575-580
68. Schaefer L et al. (2002) Absence of decorin adversely influences tubulointerstitial fibrosis of the obstructed kidney by enhanced apoptosis and increased inflammatory reaction. Am J Pathol 160: 1181-1191
69. Fern RJ et al. (1999) Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice. J Clin Invest 103: 39-46
70. Shin GT et al. (2005) Effects of suppressing intrarenal angiotensinogen on renal transforming growth factor-β1 expression in acute ureteral obstruction. Kidney Int 67: 897-908
71. Chen CO et al. (2005) Angiotensin converting enzyme inhibition worsens renal interstitial injury from unilateral ureteral obstruction in the neonatal rat. J Am Soc Nephrol 17: 222A
72. Morrissey JJ et al. (1996) Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy. J Am Soc Nephrol 7: 2202-2212
73. Schanstra JP et al. (2002) In vivo bradykinin B2 receptor activation reduces renal fibrosis. J Clin Invest 110: 371-379
74. Fukuda K et al. (2001) Quantification of TGF-β1 mRNA along rat nephron in obstructive nephropathy. Am J Physiol Renal Physiol 281: F513-F521
75. Kaneto H et al. (1999) Increased expression of TGF-β1 but not of its receptors contributes to human obstructive nephropathy. Kidney Int 56: 2137-2146
76. Isaka Y et al. (2000) Transforming growth factor-β1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction. Kidney Int 58: 1885-1892
77. Zavadil J et al. (2001) Genetic programs of epithelial cell plasticity directed by transforming growth factor-β. Proc Natl Acad Sci USA 98: 6686-6691
78. Fukasawa H et al. (2004) Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice. Proc Natl Acad Sci USA 101: 8687-8692
79. Sato M et al. (2003) Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest 112: 1486-1494
80. Inazaki K et al. (2004) Smad3 deficiency attenuates renal fibrosis, inflammation, and apoptosis after unilateral ureteral obstruction. Kidney Int 66: 597-604
81. Lan HY et al. (2003) Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model. J Am Soc Nephrol 14: 1535-1548
82. Yang J et al. (2003) Downregulation of Smad transcriptional corepressors SnoN and Ski in the fibrotic kidney: an amplification mechanism for TGF-β1 signaling. J Am Soc Nephrol 14: 3167-3177
83. Yang J and Liu Y (2002) Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J Am Soc Nephrol 13: 96-107
84. Yang J et al. (2003) Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction. Am J Pathol 163: 621-632
85. Yang J et al. (2005) A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition. J Am Soc Nephrol 16: 68-78
86. Yang J and Liu Y (2003) Delayed administration of hepatocyte growth factor reduces renal fibrosis in obstructive nephropathy. Am J Physiol 284: F349-F357
87. Wamsley-Davis A et al. (2004) AT1A-mediated activation of kidney JNK1 and SMAD2 in obstructive uropathy: preservation of kidney tissue mass using candesartan. Am J Physiol Renal Physiol 287: F474-F480
88. Yang J et al. (2002) Hepatocyte growth factor gene therapy and angiotensin II blockade synergistically attenuate renal interstitial fibrosis in mice. J Am Soc Nephrol 13: 2464-2477
89. Nakamura H et al. (2002) Introduction of DNA enzyme for Egr-1 into tubulointerstitial fibroblasts by electroporation reduced interstitial alpha-smooth muscle actin expression and fibrosis in unilateral ureteral obstruction (UUO) rats. Gene Ther 9: 495-502
90. Taneda S et al. (2003) Obstructive uropathy in mice and humans: potential role for PDGF-D in the progression of tubulointerstitial injury. J Am Soc Nephrol 14: 2544-2555
91. Ludewig D et al. (2000) PDGF receptor kinase blocker AG1295 attenuates interstitial fibrosis in rat kidney after unilateral obstruction. Cell Tissue Res 299: 97-103
92. Yokoi H et al. (2001) Role of connective tissue growth factor in profibrotic action of transforming growth factor-β: a potential target for preventing renal fibrosis. Am J Kidney Dis 38 (Suppl): S134-S138
93. Yokoi H et al. (2004) Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulinterstitial fibrosis. J Am Soc Nephrol 15: 1430-1440
94. Stambe C et al. (2004) The role of p38a mitogen-activated protein kinase activation in renal fibrosis. J Am Soc Nephrol 15: 370-379
95. Ishidoya S et al. (2002) Plasminogen activator inhibitor-1 and tissue-type plasminogen activator are up-regulated during unilateral ureteral obstruction in adult rats. J Urol 167: 1503-1507
96. Oda T et al. (2001) PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction. Kidney Int 60: 587-596
97. Matsuo S et al. (2005) Multifunctionality of PAI-1 in fibrogenesis: evidence from obstructive nephropathy in PAI-1-overexpressing mice. Kidney Int 67: 2221-2238
98. Yang JW et al. (2002) Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy. J Clin Invest 110: 1525-1538
99. Zhang G et al. (2005) Urokinase receptor deficiency accelerates renal fibrosis in obstructive nephropathy. J Am Soc Nephrol 14: 1254-1271
100. Kim HS et al. (2001) TIMP-1 deficiency does not attenuate interstitial fibrosis in obstructive nephropathy. J Am Soc Nephrol 12: 736-748
101. CIP1/WAF1 limits interstitial cell proliferation following ureteric obstruction. Am J Physiol Renal Physiol 277: F948-F956
102. Morrissey J et al. (2002) Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function. J Am Soc Nephrol 13: S14-S21
103. Lin J et al. (2005) Kielin/chordin-like protein, a novel enhancer of BMP signaling, attenuates renal fibrotic disease. Nat Med 11: 387-393
104. Abreu JG et al. (2002) Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-β. Nat Cell Biol 4: 599-604
105. Ingelfinger JR (2003) Forestalling fibrosis. N Engl J Med 349: 2265-2266
106. Fogo AB (2003) The potential for regression of renal scarring. Curr Opin Nephrol Hypertens 12: 223-225
107. Chevalier RL (2004) Biomarkers of congenital obstructive nephropathy: past, present and future. J Urol 172: 852-857
108. Valles P et al. (2003) Role of endogenous nitric oxide in unilateral ureteroplevic junction obstruction in children. Kidney Int 63: 1104-1115
109. El Sherbiny MT et al. (2002) Role of urinary transforming growth factor-β1 concentration in the diagnosis of upper urinary tract obstruction in children. J Urol 168: 1798-1800
110. Furness PD III et al. (1999) Elevated bladder urine concentration of transforming growth factor-β1 correlates with upper urinary tract obstruction in children. J Urol 162: 1033-1036
111. Yang BY et al. (2003) The expression of epidermal growth factor and transforming growth factor-β1 in the stenotic tissue of congenital pelvi-ureteric junction obstruction in children. J Pediatr Surg 38: 1656-1660
112. Grandaliano G et al. (2000) MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy. Kidney Int 58: 182-192
113. Stephan M et al. (2002) Urinary concentration and tissue messenger RNA expression of monocyte chemoattractant protein-1 as an indicator of the degree of hydronephrotic atrophy in partial ureteral obstruction. J Urol 167: 1497-1502
114. Chiou YY et al. (2004) Factors associated with the outcomes of children with unilateral ureteropelvic junction obstruction. J Urol 171: 397-402
115. Seseke F et al. (2004) Characterization of an animal model of spontaneous congenital unilateral obstructive uropathy by cDNA microarray analysis. Eur Urol 45: 374-381
116. Chevalier RL (2004) Perinatal obstructive nephropathy. Semin Nephrol 28: 124-131
117. Chevalier RL et al. (1996) Renal apoptosis and clusterin following ureteral obstruction: the role of maturation. J Urol 156: 1474-1479
118. Chevalier RL et al. (1999) Recovery following relief of unilateral ureteral obstruction in the neonatal rat. Kidney Int 55: 793-807
119. Fujinaka H et al. (2000) Salutary role for angiotensin in partial urinary tract obstruction. Kidney Int 58: 2018-2027
120. Yoo KH et al. (2005) Inducible nitric oxide synthase modulates hydronephrosis following partial or complete unilateral ureteral obstruction in the neonatal mouse. J Am Soc Nephrol 17: 421A
121. Seseke F et al. (2001) Impaired nephrogenesis in rats with congenital obstructive uropathy. J Urol 165: 2289-2292
122. Bascands JL and Schanstra JP (2005) Obstructive nephropathy: insights from genetically engineered animals. Kidney Int 68: 925-937
123. Imai E (2003) Gene therapy for renal diseases: its potential and limitation. J Am Soc Nephrol 14: 1102-1104
124. Ito K et al. (2004) Liposome-mediated gene therapy in the kidney. Human Cell 17: 17-28